Device Malfunctions Reported In Beta-Cath PMA Submission Not Significant

A number of "minor device malfunctions" reported in Novoste's Beta-Cath radiation system premarket approval application do not detract from the device's efficacy, members of FDA's Circulatory System Devices Panel agreed Sept. 11.